TechNavio's analysts forecast the Nanotechnology Drug Delivery market in the US to grow at a CAGR of 84.79 percent over the period 2012-2016. One of the key factors contributing to this market growth is the low R&D cost. The Nanotechnology Drug Delivery market in the US has also been witnessing the trend of emergence of personalized medicines. However, the increasing safety concerns could pose a challenge to the growth of this market.
TechNavio's report, the Nanotechnology Drug Delivery Market in the US 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. It also covers the Nanotechnology Drug Delivery market in the US landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors dominating this space include Alkermes plc.,Celgene Corp., Novartis AG and SkyePharma plc .
Other vendors mentioned in the report are Merck & Co. Inc., Pfizer Inc., AlphaRx Inc., Amgen, Inc., Angiotech Pharmaceuticals, Inc., Biophan Technologies, Inc., Calando Pharmaceuticals, Inc., Cephalon, Inc., Cerulean Pharma, Inc, Copernicus Therapeutics, Inc., CritiTech, Inc., CytImmune Sciences, Inc., Elan Corporation, plc, Debiotech SA, F. Hoffmann-La Roche Ltd, Nano Interface Technology, Inc, Spherics, Inc., Spectrum Pharmaceuticals, Inc., SoluBest Ltd., Sigma-Tau Pharmaceuticals, Inc., PharmaNova Inc. Particle Sciences, Inc., Novavax, Inc., Nanotherapeutics, Inc., NanoSight Ltd., NanoCarrier Co. Ltd., NanoBioMagnetics, Inc., Nano Interface Technology, Inc, Merck Sharp & Dohme Corp., Kuecept Ltd., Izon Science Ltd.
Key questions answered in this report:
What will the market size be in 2016 and at what will be the growth rate?
What are key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by key vendors?
What are the strengths and weaknesses of each of these key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details provided within the report.
01. Executive Summary
02. List of Abbreviations
03. Introduction
04. Scope of the Report
Market Overview
05. Market Landscape
05.1Nanotechnology Drug Delivery Market in the US
Market Size and Forecast
05.2Global Nanotechnology Drug Delivery Market Segmentation
05.3Five Force Analysis
06. Vendor Landscape
07. Buying Criteria
08. Market Growth Drivers
09. Drivers and their Impact
10. Market Challenges
11. Impact of Drivers and Challenges
12. Market Trends
13. Key Vendor Analysis
13.1 Alkermes plc
Business Overview
Key Information
SWOT Analysis
13.2 Celgene Corp.
Business Overview
Key Information
SWOT Analysis
13.3 SkyePharma plc
Business Overview
SWOT Analysis
13.4 Novartis AG
Business Overview
Key Information
SWOT Analysis
14. Other Reports in this Series
List of Exhibits:
Exhibit 1: Nanotechnology Drug Delivery Market in the US 2012-2016(US$ million)
Exhibit 2: Global Nanotechnology Drug Delivery Market Segmentation by Technology
Exhibit 3: Global Nanotechnology Drug Delivery Market Segmentation 2012(percent)
Contact us at the Consulting WP office nearest to you or submit a business inquiry online.
Subscribe to Our Newsletter
Published On : December 2019
$ 3600
Published On : December 2019
$ 3600
